FDA notifications. Changes to ART guidelines detailed by the FDA.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D017408:Guidelines as Topic; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D014376:Tuberculosis / Q000150:complications; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents